Login

Erik Kinnman, CEO, NeuroVive Pharmaceutical 00:00:00

Share On Facebook Share On Twitter

NeuroVive Pharmaceutical - Company presentation

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Next Demba Sow from Alsace France pitched Hodi Hodi|Vincent Diallo,Founder & General Partner,Interlace Ventures
00:10:00
Interview with Anthony Jabbour, CEO Black Knight | Anythony Jabbour, CEO, Black Knight IncBKI:NYQ
00:10:00
Strategic Outlook: Economic Trends and Investment Insights with Alex Shivananda | Alex Shivananda, Managing Director, Cambridge Associates LLC.
00:10:00
Pear is the most extraordinary early-stage investment firm ever created|Pejman Nozad,partner,Pear VC
00:10:00
Market Trends This Fall: Understanding the Slide | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
Self-Storage Secrets to Financial Freedom: Insights from Caley Acevez - Caley Acevez | VP of Marketing | Cedar Creek Capital
00:10:00
Actinogen CEO Steve Goulet Discusses Promising Alzheimer's Treatment and Company Growth|Dr Steven Gourlay,CEO,Actinogen Medical
00:10:00
Lithium Australia: Pioneering Vertically Integrated Lithium Processing Technology
00:10:00
China's Investment Prospects: A Conversation with Dato’ Seri Cheah Cheng Hye and Tang Ning | Dato’ Seri Cheah Cheng Hye, Co-Chairman , Value Partners .
00:10:00
Private Equity's Strategic Moves in European Financial Sector | Steve Pierson, President , Lovell Minnick Partners .
00:10:00
Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta
00:10:00
Indian Equity Markets: Resilience and Strategic Outlook | Nimesh Shah, CEO , ICICI Prudential Mutual Fund .

© 2017 - Neuhu+